Important update on Vertex trials

Petri Dish: Vertex halts type 1 diabetes trial; Watertown manufacturer sold

This past week, a Watertown cell and gene therapy manufacturer was bought, Vertex halted a clinical trial for Type 1 diabetes and Repare lost its CEO just a month after major layoffs.

Important update on Vertex trials

A large area of cure-based T1D research is investigating stem cell-based therapy. The goal of this approach is to use stem cells as a renewable source of insulin-producing cells which, when transplanted, would replace beta cells that are destroyed in a person with T1D, thereby allowing them to produce insulin again. This would lessen or eliminate the amount of external insulin required by someone living with T1D (either by injection, pen, or pum…